Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Immunodeficiency due to MASP-2 deficiency is a rare, genetic immunodeficiency due to a complement cascade protein anomaly characterized by low serum levels of MASP-2 and a variable susceptibility to bacterial infections (e.g. pulmonary tuberculosis, pneumococcal pneumonia, skin abscesses and sepsis), and autoimmune diseases (e.g. inflammatory lung disease, cystic fibrosis, systemic lupus erythematosus). In many cases it remains asymptomatic.
Features include always present findings: Ulcerative colitis, Reduced circulating complement concentration, Systemic lupus erythematosus, and Recurrent pneumonia.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Digestive system | 1 | Ulcerative colitis |
MASP2 encodes MBL associated serine protease 2 (686 aa). Precursor of a serum protease that activates the lectin pathway of the complement system, a cascade of proteins that leads to phagocytosis and breakdown of pathogens and signaling that strengthens the adaptive immune system. Highest expression in Liver (119.6 TPM) and Brain Cerebellar Hemisphere (18.0 TPM).
Immunodeficiency due to MASP-2 deficiency is associated with mutations in the MASP2 gene on chromosome 1.
The MASP2 protein participates in SERPING1 variant is not secreted and Activated MASP2-1 pathways.
MASP2 is classified as a druggable target (Druggable Genome, Enzyme, and Protease categories) with score 104.4.
Genetic testing for MASP2 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 4 always present features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for immunodeficiency due to MASP-2 deficiency.
1 publication has been identified in PubMed for immunodeficiency due to MASP-2 deficiency. Research spans Review / Meta-Analysis (100%).
García-Soidán A (2025). [PMID: 40513623](https://pubmed.ncbi.nlm.nih.gov/40513623/). *The Journal of allergy and clinical immunology*. [Review / Meta-Analysis]
Data assembled from 6 of 12 sources · Last updated Sep 19, 2026, 5:37 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
1 |
Systemic lupus erythematosus |
Lungs and breathing | 1 | Recurrent pneumonia |